| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRISTOL MYERS SQUIBB CO | Director | Deferred Share Units | 37,903 | $2,086,568 | $55.05 | 01 Feb 2026 | Direct |
| EYENOVIA, INC. | Director | Stock Option (right to buy) | 30,769 | $184,922 | $6.01 | 16 Jun 2022 | Direct |
| EYENOVIA, INC. | Director | Common Stock, par value $.0001 | 30,408 | $41,355 | $1.36 | 16 Jun 2022 | Direct |
| Outlook Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 58,648 | 03 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BMY | BRISTOL MYERS SQUIBB CO | 01 Feb 2026 | 1 | +$220,000 | 4 | Director | 03 Feb 2026, 16:22 |
| OTLK | Outlook Therapeutics, Inc. | 01 Oct 2025 | 2 | $0 | 4 | Director | 03 Oct 2025, 20:12 |
| BMY | BRISTOL MYERS SQUIBB CO | 01 Feb 2025 | 1 | +$210,000 | 4 | Director | 04 Feb 2025, 19:13 |
| OTLK | Outlook Therapeutics, Inc. | 01 Oct 2024 | 3 | $0 | 4 | Director | 03 Oct 2024, 20:30 |
| OTLK | Outlook Therapeutics, Inc. | 07 Mar 2024 | 1 | $0 | 4 | Director | 08 Mar 2024, 16:30 |
| BMY | BRISTOL MYERS SQUIBB CO | 01 Feb 2024 | 1 | +$210,000 | 4 | Director | 05 Feb 2024, 19:17 |
| BMY | BRISTOL MYERS SQUIBB CO | 31 Dec 2023 | 1 | +$36,250 | 4 | Director | 03 Jan 2024, 17:36 |
| OTLK | Outlook Therapeutics, Inc. | 04 Oct 2023 | 1 | $0 | 4 | Director | 05 Oct 2023, 17:15 |
| BMY | BRISTOL MYERS SQUIBB CO | 30 Sep 2023 | 1 | +$36,250 | 4 | Director | 03 Oct 2023, 18:31 |
| BMY | BRISTOL MYERS SQUIBB CO | 30 Jun 2023 | 1 | +$35,425 | 4 | Director | 05 Jul 2023, 17:31 |
| BMY | BRISTOL MYERS SQUIBB CO | 31 Mar 2023 | 1 | +$33,750 | 4 | Director | 04 Apr 2023, 20:37 |
| OTLK | Outlook Therapeutics, Inc. | 29 Mar 2023 | 1 | $0 | 4 | Director | 31 Mar 2023, 17:49 |
| BMY | BRISTOL MYERS SQUIBB CO | 01 Feb 2023 | 1 | +$200,000 | 4 | Director | 03 Feb 2023, 18:19 |
| BMY | BRISTOL MYERS SQUIBB CO | 31 Dec 2022 | 1 | +$33,750 | 4 | Director | 04 Jan 2023, 16:25 |
| OTLK | Outlook Therapeutics, Inc. | 05 Oct 2022 | 1 | $0 | 4 | Director | 07 Oct 2022, 16:35 |
| BMY | BRISTOL MYERS SQUIBB CO | 30 Sep 2022 | 1 | +$33,750 | 4 | Director | 04 Oct 2022, 21:16 |
| OTLK | Outlook Therapeutics, Inc. | 11 Aug 2022 | 1 | $0 | 4 | Director | 15 Aug 2022, 17:16 |
| OTLK | Outlook Therapeutics, Inc. | 11 Aug 2022 | 0 | $0 | 3 | Director | 15 Aug 2022, 17:14 |
| BMY | BRISTOL MYERS SQUIBB CO | 30 Jun 2022 | 1 | +$33,750 | 4 | Director | 05 Jul 2022, 16:28 |
| EYEN | EYENOVIA, INC. | 16 Jun 2022 | 2 | $0 | 4 | Director | 21 Jun 2022, 14:28 |
| BMY | BRISTOL MYERS SQUIBB CO | 03 Jun 2022 | 2 | $0 | 4 | Director | 07 Jun 2022, 17:50 |
| BMY | BRISTOL MYERS SQUIBB CO | 31 Mar 2022 | 1 | +$33,750 | 4 | Director | 04 Apr 2022, 18:14 |
| BMY | BRISTOL MYERS SQUIBB CO | 01 Feb 2022 | 1 | +$200,000 | 4 | Director | 03 Feb 2022, 17:04 |
| BMY | BRISTOL MYERS SQUIBB CO | 31 Dec 2021 | 1 | +$32,500 | 4 | Director | 04 Jan 2022, 17:21 |
| EYEN | EYENOVIA, INC. | 17 Nov 2021 | 2 | $0 | 4 | Director | 22 Nov 2021, 08:22 |
| BMY | BRISTOL MYERS SQUIBB CO | 30 Sep 2021 | 1 | $0 | 4 | Director | 01 Oct 2021, 16:31 |
| BMY | BRISTOL MYERS SQUIBB CO | 30 Jun 2021 | 1 | $0 | 4 | Director | 01 Jul 2021, 17:16 |
| BMY | BRISTOL MYERS SQUIBB CO | 13 Jun 2021 | 2 | $0 | 4 | Director | 14 Jun 2021, 18:56 |
| BMY | BRISTOL MYERS SQUIBB CO | 03 Jun 2021 | 2 | $0 | 4 | Director | 04 Jun 2021, 16:35 |